12:00 AM
 | 
Apr 24, 2000
 |  BC Week In Review  |  Company News  |  Other News

Eukarion Inc. other research news

Eukarion received a $1.3 million Phase II SBIR grant from the National Institute of General Medical...

Read the full 60 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >